乳腺康凝胶膏剂治疗乳腺增生临床研究  被引量:19

Clinical Effects on the Treatment of Hyperplasia of Mammary Glands by Ruxian Kang Gel

在线阅读下载全文

作  者:李伟泽[1,2] 刘世泽[3] 崔竹玲 孔朋 

机构地区:[1]西安医学院,陕西西安710021 [2]山西丰源药业有限公司,山西芮城044600 [3]北车集团永济电机厂医院,山西永济044502

出  处:《中医学报》2015年第8期1218-1220,共3页Acta Chinese Medicine

基  金:山西省科技厅-创新药物研制重大专项(20121101014)

摘  要:目的:观察乳腺康凝胶膏剂治疗乳腺增生的临床疗效。方法:将180例乳腺增生患者随机分为治疗组和对照组,每组90例。治疗组给予乳腺康凝胶膏剂贴敷于乳腺增生的肿块和疼痛显著处,每日更换1次,15 d为1个疗程,共治疗2个疗程;对照组口服乳癖消胶囊治疗,每日3次,每次2粒,共治疗30 d。两组均治疗后观察临床疗效。结果:治疗组治愈72例,占80%;显效15例,占16.67%;有效2例,占2.22%;无效1例,占1.11%;有效率为98.89%。对照组治愈57例,占63.33%;显效8例,占8.89%;有效17例,占18.89%;无效8例,占8.89%;有效率为91.11%。两组患者均未出现明显不良反应。结论:乳腺康凝胶膏剂治疗乳腺增生疗效显著,使用方便,安全可靠,且无不良反应。Objective:To observe the clinical effects on the treatment of hyperplasia of mammary glands by Ruxian kang gel. Methods: 180cases were randomly divided into treatment group and control group, each group was 90 case. The treatment group was given Ruxian kang gel,which pasted the lump and pain location, ltime a day, lcourse is 15d,for treating 2 courses. The control group was given Rupi xiao capsules. 3times a day,2 particles a time, for treating 30d, After the treatment, observing the clinical effects. Results:In the treat- ment group,the patients had been cured 72cases, accounted for 80% ;15 cases were markedly improved (16.67%), Effective in 2 ca- ses, accounting for 2.22% ; Invalid in 1 case ( 1.11% ), The effective rate was 98.89%. In the control group, the patients had been cured 57 cases(63.33% ) ,8 cases were markedly improved( 8.89% ), Effective 17 cases ( 18.89% ), Invalid 8 cases (8.89%) , The effective rate was 91.11%. In the two groups were not significant adverse reactions. Conclusion:Ruxian kang gel in treating hyperplasia of mammary glands is remarkable curative effect, and easy to use, safe and reliable, and no adverse reactions.

关 键 词:乳腺增生 乳腺康凝胶膏剂 乳癖消胶囊 

分 类 号:R271.44[医药卫生—中医妇科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象